TABLE OF CONTENTS
October 11, 1999
Volume 77, Number 41
CENEAR 77 41 p. 3
ISSN 0009-2347

NEWS OF THE WEEK

TERMINATOR SEEDS:   17
Monsanto won't develop sterile second-generation seed technology.

ICI SELLS ACRYLICS:   17
Transformation to specialty chemicals firm nearly complete.

ENZYME MIMIC:  18
Small synthetic complex mirrors action of superoxide dismutase.

FOREIGN POLICY & SCIENCE:   18
NRC tells State Department how to beef up its technical expertise.

JAPAN'S NUCLEAR ACCIDENT:  19
As effect of human errors multiplied, everything that could go wrong did.

DOE 2000 BUDGET:  20
Congress gives department less than it wanted for science, security.

MENTORING:   20
Of 10 1999 presidential award winners, four have ties to chemistry.

BUSINESS

BUSINESS CONCENTRATES:23

Y2K READINESS:   27
Small chemical firms' tactics range from methodical preparation to "fix it if it breaks."

SCI MEDALIST WILSON:   31
Rohm and Haas' recently retired chairman and CEO is honored.

SGI:   40
Reorganized maker of high-end computers entices researchers.

DOW'S RUBBER PLANS:   47
Firm ponders a strategy for its variously acquired assets.

GOVERNMENT & POLICY

GOVERNMENT CONCENTRATES:51

SPACE RESEARCH:   53
Chemically based research aboard shuttles is praised by some, dismissed by others.

NIH PEER REVIEW:   72
Proposed overhaul raises concerns about future of chemistry in agency's research.

CHEMICAL HINDSIGHTS:   78
CIA report about missile threats is unusually perceptive.

SCIENCE/TECHNOLOGY

SCIENCE/TECHNOLOGY CONCENTRATES:81

RIBOSOME STRUCTURE:   83
X-ray crystal structures begin to reveal details of how cells make proteins.

APPLIED CATALYSIS:   88
British institute pioneers unusual approach to industry-university collaboration.

POLYURETHANES:   92
Synthesis from single building block accomplished.

FLUORESCENCE:   95
Six proteins cloned from coral emit range of colors and may be used in molecule labeling.

CAREERS

CHANGING TRACKS:   99
Technicians find rewards in new outlets for their skills.

SPECIAL REPORT

COVER STORY

CHIRAL DRUGS:   101
Issues ranging from drug delivery systems to defense against generics swirl around the topic of chirality.

THE DEPARTMENTS

 7 EDITOR'S PAGE

 10 LETTERS

 96 SOFTWARE/ONLINE BRIEFS

123 BOOKS

126 ACS COMMENT

127 PEOPLE

152 NEWSCRIPTS


Chemical & Engineering News
Copyright © 1999 American Chemical Society